Prevalence of BPH and lower urinary tract symptoms in West Africans

Prostate Cancer and Prostatic Diseases

Volumn 15, Issue 2, 2012, Pages 170-176

  Chokkalingam, A P ^a   Yeboah, E D ^b   DeMarzo, A ^c   Netto, G ^c   Yu, K ^d   Biritwum, R B ^b   Tettey, Y ^b   Adjei, A ^b   Jadallah, S ^c   Li, Y ^d   Chu, L W ^d   Chia, D ^e   Niwa, S ^f   Partin, A ^c   Thompson, I M ^g   Roehrborn, C ^h   Hoover, R N ^d   Hsing, A W ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF GHANA   (Ghana)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f WESTAT   (United States)

^g UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^h UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Africa; BPH; DRE; PSA

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; DEVELOPING COUNTRY; DIGITAL RECTAL EXAMINATION; EUROPEAN AMERICAN; GHANA; HUMAN; HUMAN TISSUE; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RACE DIFFERENCE; RISK ASSESSMENT; RISK FACTOR; STANDARDIZATION; TRANSRECTAL ULTRASONOGRAPHY;

AFRICAN AMERICANS; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; DIGITAL RECTAL EXAMINATION; GHANA; HUMANS; LOWER URINARY TRACT SYMPTOMS; MALE; MIDDLE AGED; PREVALENCE; PROSTATIC HYPERPLASIA; SELF REPORT;

EID: 84861228160     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/pcan.2011.43     Document Type: Article

References (28)

1. Wei JT, Calhoun EA, Jacobsen SJ. Benign Prostatic hyperplasia. In: Litwin MS, Saigal CS (eds). Urologic Diseases in America. DHHS, PHS, NIH, NIDDK-Government Printing Office: Washington, DC, 2007; pp 43-67
2. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol 1984; 132: 474-479
3. Oesterling JE. Benign prostatic hyperplasia: a review of its histogenesis and natural history. Prostate Suppl 1996; 6: 67-73
4. Girman CJ. Population-based studies of the epidemiology of benign prostatic hyperplasia. Br J Urol 1998; 82 (Suppl 1): 34-43
5. Barry MJ, Fowler Jr FJ, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 1992; 148: 1549-1557
6. Bosch JL, Hop WC, Kirkels WJ, Schroder FH. The International Prostate Symptom Score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume. Br J Urol 1995; 75: 622-630
7. Sarma AV, Wei JT, Jacobson DJ, Dunn RL, Roberts RO, Girman CJ et al. Comparison of lower urinary tract symptom severity and associated bother between community-dwelling black and white men: the Olmsted County Study of Urinary Symptoms and Health Status and the Flint Men's Health Study. Urology 2003; 61: 1086-1091
8. Kok ET, Bohnen AM, Jonkheijm R, Gouweloos J, Groeneveld FP, Thomas S et al. Simple case definition of clinical benign prostatic hyperplasia, based on International Prostate Symptom Score, predicts general practitioner consultation rates. Urology 2006; 68: 784-789
9. Naslund MJ, Gilsenan AW, Midkiff KD, Bown A, Wolford ET, Wang J. Prevalence of lower urinary tract symptoms and prostate enlargement in the primary care setting. Int J Clin Pract 2007; 61: 1437-1445
10. Markland AD, Thompson IM, Ankerst DP, Higgins B, Kraus SR. Lack of disparity in lower urinary tract symptom severity between community-dwelling non-Hispanic white, Mexican- American, and African-American men. Urology 2007; 69: 697-702
11. Glasser DB, Carson 3rd C, Kang JH, Laumann EO. Prevalence of storage and voiding symptoms among men aged 40 years and older in a US population-based study: results from the Male Attitudes Regarding Sexual Health study. Int J Clin Pract 2007; 61: 1294-1300
12. Trueman P, Hood SC, Nayak US, Mrazek MF. Prevalence of lower urinary tract symptoms and self-reported diagnosed 'benign prostatic hyperplasia', and their effect on quality of life in a community-based survey of men in the UK. BJU Int 1999; 83: 410-415
13. Norman RW, Nickel JC, Fish D, Pickett SN. 'Prostate-related symptoms' in Canadian men 50 years of age or older: prevalence and relationships among symptoms. Br J Urol 1994; 74: 542-550
14. Sagnier PP, MacFarlane G, Richard F, Botto H, Teillac P, Boyle P. Results of an epidemiological survey using a modified American Urological Association symptom index for benign prostatic hyperplasia in France. J Urol 1994; 151: 1266-1270
15. Braun MH, Sommer F, Haupt G, Mathers MJ, Reifenrath B, Engelmann UH. Lower urinary tract symptoms and erectile dysfunction: co-morbidity or typical 'Aging Male' symptoms? Results of the 'Cologne Male Survey'. Eur Urol 2003; 44: 588-594
16. Rosen R, Altwein J, Boyle P, Kirby RS, Lukacs B, Meuleman E et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol 2003; 44: 637-649
17. Kupelian V, Wei JT, O'Leary MP, Kusek JW, Litman HJ, Link CL et al. Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston Area Community Health (BACH) Survey. Arch Intern Med 2006; 166: 2381-2387
18. Taylor BC, Wilt TJ, Fink HA, Lambert LC, Marshall LM, Hoffman AR et al. Prevalence, severity, and health correlates of lower urinary tract symptoms among older men: the MrOS study. Urology 2006; 68: 804-809
19. Parsons JK, Bergstrom J, Silberstein J, Barrett-Connor E. Prevalence and characteristics of lower urinary tract symptoms in men aged 4 or 80 years. Urology 2008; 72: 318-321
20. Boyle P, Robertson C, Mazzetta C, Keech M, Hobbs FD, Fourcade R et al. The prevalence of lower urinary tract symptoms in men and women in four centres. The UrEpik study. BJU Int 2003; 92: 409-414
21. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T et al. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96
22. Platz EA, Kawachi I, Rimm EB, Willett WC, Giovannucci E. Race, ethnicity and benign prostatic hyperplasia in the health professionals follow-up study. J Urol 2000; 163: 490-495
23. Platz EA, Smit E, Curhan GC, Nyberg LM, Giovannucci E. Prevalence of and racial/ethnic variation in lower urinary tract symptoms and noncancer prostate surgery in US men. Urology 2002; 59: 877-883
24. Roehrborn CG, Boyle P, Gould AL, Waldstreicher J. Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia. Urology 1999; 53: 581-589
25. Bosch JL, Bohnen AM, Groeneveld FP. Validity of digital rectal examination and serum prostate specific antigen in the estimation of prostate volume in community-based men aged 50-78 years: the Krimpen Study. Eur Urol 2004; 46: 753-759
26. SUDAAN Language Manual, Release 9.0. Research Triangle Institute: Research Triangle Park, NC, 2004
27. Ahmad OE, Boschi-Pinto C, Lopez AD, Murray CJ, Lozano R, Inoue M. Age standardization of rates: a new WHO standard. GPE Discussion Paper Series.World Health Organization: Geneva, 2000
28. Guess HA, Arrighi HM, Metter EJ, Fozard JL. Cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia. Prostate 1990; 17: 241-246